[Drug therapy of tachycardic atrial arrhythmias].
There are defined indications for the acute pharmacological management of AV-nodal reentry tachycardias, AV reentry tachycardias and for the acute and chronic ventricular rate control in atrial fibrillation. Possible indications arise for the chronic pharmacologic therapy of AV reentry tachycardias, pharmacological cardioversion and prophylaxis of atrial fibrillation. In future there will be a trend towards nonpharmacological management of atrial arrhythmias.
Wietholt
D
D
Medizinische Klinik B, Herzzentrum der Universität Witten/Herdecke. Wuppertal.
Gülker
H
H
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D003131:Combined Modality Therapy; D004554:Electric Countershock; D004562:Electrocardiography / Q000187:drug effects; D006801:Humans; D013611:Tachycardia, Atrioventricular Nodal Reentry / Q000188:drug therapy* / Q000209:etiology; D013617:Tachycardia, Supraventricular / Q000188:drug therapy* / Q000209:etiology
D000889:Anti-Arrhythmia Agents